Multiple sclerosis management products in development in the U.S. 2014

This statistic displays the number of products in development for multiple sclerosis (MS) management as of 2014, in the United States. As of July 2014, 15 such products were in Phase 2 of development. There are about 350,000 to 500,000 people in the country that are diagnosed with the disease. MS is a disease that damages nerve cells in the brain and spinal cord which disrupts the ability of the nervous system to communicate with the body.

Number of multiple sclerosis drugs in development in the United States as of July 2014

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

July 2014

Region

United States

Survey time period

July 2014

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 / Month *
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Pharmaceutical industry in the United Kingdom (UK)"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.